Michael W. Freeman
Stock Analyst at Raymond James
(1.98)
# 3,348
Out of 4,792 analysts
48
Total ratings
35.3%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: PRN Profound Medical Corp. | Reiterated: Buy | n/a | $8.20 | - | 6 | Aug 7, 2026 | |
| TSX: VHI Vitalhub Corp. | Reiterated: Buy | n/a | $7.52 | - | 7 | Aug 7, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | n/a | $4.03 | - | 6 | Aug 7, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $36.00 | $33.35 | +7.95% | 1 | Jul 6, 2026 | |
| TSX: AIDX Healwell AI Inc. | Reiterated: Buy | $3.00 → $2.50 | $0.75 | +233.33% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Reiterated: Buy | $6.00 → $7.00 | $3.73 | +87.67% | 2 | Nov 18, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Reiterated: Buy | $8.00 | $5.01 | n/a | 9 | Aug 14, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | $11.07 | $8.42 | n/a | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Reiterated: Buy | $3.25 → $4.34 | $2.16 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Reiterated: Buy | $8.00 | $9.73 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.50 | $0.30 | n/a | 1 | Nov 18, 2024 |
Profound Medical Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.20
Upside: -
Vitalhub Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.52
Upside: -
WELL Health Technologies Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.03
Upside: -
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $33.35
Upside: +7.95%
Healwell AI Inc.
Mar 25, 2026
Reiterated: Buy
Price Target: $3.00 → $2.50
Current: $0.75
Upside: +233.33%
HLS Therapeutics Inc.
Nov 18, 2025
Reiterated: Buy
Price Target: $6.00 → $7.00
Current: $3.73
Upside: +87.67%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Reiterated: Buy
Price Target: $8.00
Current: $5.01
Upside: n/a
Bausch Health Companies Inc.
Aug 5, 2025
Reiterated: Hold
Price Target: $11.07
Current: $8.42
Upside: n/a
NervGen Pharma
Jun 11, 2025
Reiterated: Buy
Price Target: $3.25 → $4.34
Current: $2.16
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Reiterated: Buy
Price Target: $8.00
Current: $9.73
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.30
Upside: n/a